{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T00:31:36Z","timestamp":1792801896628,"version":"4.5.0"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,5,26]],"date-time":"2022-05-26T00:00:00Z","timestamp":1653523200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,5,26]],"date-time":"2022-05-26T00:00:00Z","timestamp":1653523200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100015755","name":"CIBERehd","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100015755","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI15\/01132"],"award-info":[{"award-number":["PI15\/01132"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI18\/01075"],"award-info":[{"award-number":["PI18\/01075"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI16\/01126"],"award-info":[{"award-number":["PI16\/01126"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["FIS PI18\/01075"],"award-info":[{"award-number":["FIS PI18\/01075"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["FIS PI21\/00922"],"award-info":[{"award-number":["FIS PI21\/00922"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002704","name":"Fundaci\u00f3n Cient\u00edfica Asociaci\u00f3n Espa\u00f1ola Contra el C\u00e1ncer","doi-asserted-by":"publisher","award":["Rare Cancers grant 2017"],"award-info":[{"award-number":["Rare Cancers grant 2017"]}],"id":[{"id":"10.13039\/501100002704","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002704","name":"Fundaci\u00f3n Cient\u00edfica Asociaci\u00f3n Espa\u00f1ola Contra el C\u00e1ncer","doi-asserted-by":"publisher","award":["AECC Postdoctoral Fellowship"],"award-info":[{"award-number":["AECC Postdoctoral Fellowship"]}],"id":[{"id":"10.13039\/501100002704","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017266","name":"Gobierno de Navarra","doi-asserted-by":"publisher","award":["58\/17"],"award-info":[{"award-number":["58\/17"]}],"id":[{"id":"10.13039\/501100017266","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Interdisziplin\u00e4res Zentrum f\u00fcr Klinische Forschung, Universit\u00e4tsklinikum Aachen","award":["#691405"],"award-info":[{"award-number":["#691405"]}]},{"name":"Sonderforschungsbereiche Transregio","award":["57"],"award-info":[{"award-number":["57"]}]},{"name":"Sonderforschungsbereiche (SFB)","award":["1382"],"award-info":[{"award-number":["1382"]}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["TR283-10\/1"],"award-info":[{"award-number":["TR283-10\/1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["TR285\/10-2 403224013"],"award-info":[{"award-number":["TR285\/10-2 403224013"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005972","name":"Deutsche Krebshilfe","doi-asserted-by":"publisher","award":["70113000"],"award-info":[{"award-number":["70113000"]}],"id":[{"id":"10.13039\/501100005972","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014180","name":"Junta de Castilla y Le\u00f3n","doi-asserted-by":"publisher","award":["SA063P17"],"award-info":[{"award-number":["SA063P17"]}],"id":[{"id":"10.13039\/501100014180","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012818","name":"Comunidad de Madrid","doi-asserted-by":"publisher","award":["EXOHEP-CM S2017\/BMD-3727"],"award-info":[{"award-number":["EXOHEP-CM S2017\/BMD-3727"]}],"id":[{"id":"10.13039\/100012818","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012818","name":"Comunidad de Madrid","doi-asserted-by":"publisher","award":["NanoLiver-CM Y2018\/NMT-4949"],"award-info":[{"award-number":["NanoLiver-CM Y2018\/NMT-4949"]}],"id":[{"id":"10.13039\/100012818","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014440","name":"Ministerio de Ciencia, Innovaci\u00f3n y Universidades","doi-asserted-by":"publisher","award":["PID2019-104878RB-100\/AEI\/10.13039\/501100011033"],"award-info":[{"award-number":["PID2019-104878RB-100\/AEI\/10.13039\/501100011033"]}],"id":[{"id":"10.13039\/100014440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014440","name":"Ministerio de Ciencia, Innovaci\u00f3n y Universidades","doi-asserted-by":"publisher","award":["PID2020-117116RB-100"],"award-info":[{"award-number":["PID2020-117116RB-100"]}],"id":[{"id":"10.13039\/100014440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014440","name":"Ministerio de Ciencia, Innovaci\u00f3n y Universidades","doi-asserted-by":"publisher","award":["SAF2014-5491-R"],"award-info":[{"award-number":["SAF2014-5491-R"]}],"id":[{"id":"10.13039\/100014440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014440","name":"Ministerio de Ciencia, Innovaci\u00f3n y Universidades","doi-asserted-by":"publisher","award":["SAF2016-78711"],"award-info":[{"award-number":["SAF2016-78711"]}],"id":[{"id":"10.13039\/100014440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014440","name":"Ministerio de Ciencia, Innovaci\u00f3n y Universidades","doi-asserted-by":"publisher","award":["SAF-2017-87301-R"],"award-info":[{"award-number":["SAF-2017-87301-R"]}],"id":[{"id":"10.13039\/100014440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014440","name":"Ministerio de Ciencia, Innovaci\u00f3n y Universidades","doi-asserted-by":"publisher","award":["SAF2017-88933-R"],"award-info":[{"award-number":["SAF2017-88933-R"]}],"id":[{"id":"10.13039\/100014440","id-type":"DOI","asserted-by":"publisher"}]},{"name":"MCIU\/AEI\/FEDER","award":["RTI2018-095134-B-100"],"award-info":[{"award-number":["RTI2018-095134-B-100"]}]},{"DOI":"10.13039\/501100003086","name":"Eusko Jaurlaritza","doi-asserted-by":"publisher","award":["IT971-16"],"award-info":[{"award-number":["IT971-16"]}],"id":[{"id":"10.13039\/501100003086","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Bio-Eusko Fundazioa","award":["BIO15\/CA\/011"],"award-info":[{"award-number":["BIO15\/CA\/011"]}]},{"name":"Bio-Eusko Fundazioa","award":["BIO15\/CA\/016\/BD"],"award-info":[{"award-number":["BIO15\/CA\/016\/BD"]}]},{"name":"Euskadi RIS3","award":["2019222054"],"award-info":[{"award-number":["2019222054"]}]},{"name":"Fundaci\u00f3n La Caixa","award":["HEPACARE Project"],"award-info":[{"award-number":["HEPACARE Project"]}]},{"name":"Fundaci\u00f3n La Caixa","award":["HR17-00601"],"award-info":[{"award-number":["HR17-00601"]}]},{"DOI":"10.13039\/501100006135","name":"ERAB: The European Foundation for Alcohol Research","doi-asserted-by":"publisher","award":["EA 18\/14"],"award-info":[{"award-number":["EA 18\/14"]}],"id":[{"id":"10.13039\/501100006135","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Uni\u00f3n Iberoamericana de Universidades","award":["UCM-25-2019"],"award-info":[{"award-number":["UCM-25-2019"]}]},{"DOI":"10.13039\/100008055","name":"Fundaci\u00f3n Eugenio Rodr\u00edguez Pascual","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008055","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Fundaci\u00f3n Ech\u00e9bano"},{"name":"Fundaci\u00f3 Mataro TV3","award":["201916-31"],"award-info":[{"award-number":["201916-31"]}]},{"name":"Fundaci\u00f3n Mario Losantos"},{"name":"Fundaci\u00f3n M Torres"},{"name":"AMMF: The Cholangiocarcinoma Charity","award":["2018\/117"],"award-info":[{"award-number":["2018\/117"]}]},{"name":"AMMF: The Cholangiocarcinoma Charity","award":["EU\/2019\/AMMFt\/001"],"award-info":[{"award-number":["EU\/2019\/AMMFt\/001"]}]},{"DOI":"10.13039\/100007406","name":"Fundaci\u00f3n BBVA","doi-asserted-by":"publisher","award":["LCR\/PR\/HP17\/52190004"],"award-info":[{"award-number":["LCR\/PR\/HP17\/52190004"]}],"id":[{"id":"10.13039\/100007406","id-type":"DOI","asserted-by":"publisher"}]},{"name":"COST Action Euro-cholangio-Net","award":["CA181122"],"award-info":[{"award-number":["CA181122"]}]},{"name":"Miguel Servet","award":["CPII19\/00008"],"award-info":[{"award-number":["CPII19\/00008"]}]},{"name":"PSC Partners US and PSC Supports UK","award":["06119JB"],"award-info":[{"award-number":["06119JB"]}]},{"name":"Horizon 2020 Research and Innovation Program","award":["825510 ESCALON"],"award-info":[{"award-number":["825510 ESCALON"]}]},{"name":"Ram\u00f3n y Cajal Program","award":["RYC-2014-15242"],"award-info":[{"award-number":["RYC-2014-15242"]}]},{"name":"Ram\u00f3n y Cajal Program","award":["RYC2018-024475-1"],"award-info":[{"award-number":["RYC2018-024475-1"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Exp Clin Cancer Res"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Cholangiocarcinoma (CCA) is still a deadly tumour. Histological and molecular aspects of thioacetamide (TAA)-induced intrahepatic CCA (iCCA) in rats mimic those of human iCCA. Carcinogenic changes and therapeutic vulnerabilities in CCA may be captured by molecular investigations in bile, where we performed bile proteomic and metabolomic analyses that help discovery yet unknown pathways relevant to human iCCA.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Cholangiocarcinogenesis was induced in rats (TAA) and mice (<jats:italic>Jnk<\/jats:italic><jats:sup><jats:italic>\u0394hepa<\/jats:italic><\/jats:sup>\u00a0+\u2009CCl<jats:sub>4<\/jats:sub>\u00a0+\u2009DEN model). We performed proteomic and metabolomic analyses in bile from control and CCA-bearing rats. Differential expression was validated in rat and human CCAs. Mechanisms were addressed in human CCA cells, including Huh28-KRAS<jats:sup>G12D<\/jats:sup> cells. Cell signaling, growth, gene regulation and [U-<jats:sup>13<\/jats:sup>C]-D-glucose-serine fluxomics analyses were performed. In vivo studies were performed in the clinically-relevant iCCA mouse model.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Pathways related to inflammation, oxidative stress and glucose metabolism were identified by proteomic analysis. Oxidative stress and high amounts of the oncogenesis-supporting amino acids serine and glycine were discovered by metabolomic studies. Most relevant hits were confirmed in rat and human CCAs (TCGA). Activation of interleukin-6 (IL6) and epidermal growth factor receptor (EGFR) pathways, and key genes in cancer-related glucose metabolic reprogramming, were validated in TAA-CCAs. In TAA-CCAs, G9a, an epigenetic pro-tumorigenic writer, was also increased. We show that EGFR signaling and mutant KRAS<jats:sup>G12D<\/jats:sup> can both activate IL6 production in CCA cells. Furthermore, phosphoglycerate dehydrogenase (PHGDH), the rate-limiting enzyme in serine-glycine pathway, was upregulated in human iCCA correlating with <jats:italic>G9a<\/jats:italic> expression. In a G9a activity-dependent manner, KRAS<jats:sup>G12D<\/jats:sup> promoted PHGDH expression, glucose flow towards serine synthesis, and increased CCA cell viability. KRAS<jats:sup>G12D<\/jats:sup> CAA cells were more sensitive to PHGDH and G9a inhibition than controls. In mouse iCCA, G9a pharmacological targeting reduced PHGDH expression.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>In CCA, we identified new pro-tumorigenic mechanisms: Activation of EGFR signaling or KRAS mutation drives IL6 expression in tumour cells; Glucose metabolism reprogramming in iCCA includes activation of the serine-glycine pathway; Mutant KRAS drives PHGDH expression in a G9a-dependent manner; PHGDH and G9a emerge as therapeutic targets in iCCA.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13046-022-02386-2","type":"journal-article","created":{"date-parts":[[2022,5,26]],"date-time":"2022-05-26T07:03:00Z","timestamp":1653548580000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["New molecular mechanisms in cholangiocarcinoma: signals triggering interleukin-6 production in tumor cells and KRAS co-opted epigenetic mediators driving metabolic reprogramming"],"prefix":"10.1186","volume":"41","author":[{"given":"Leticia","family":"Colyn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gloria","family":"Alvarez-Sola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Ujue","family":"Latasa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iker","family":"Uriarte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose M.","family":"Herranz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Arechederra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Vlachogiannis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colin","family":"Rae","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Pineda-Lucena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Casadei-Gardini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Pedica","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Aldrighetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angeles","family":"L\u00f3pez-L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angeles","family":"L\u00f3pez-Gonz\u00e1lvez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Coral","family":"Barbas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio","family":"Ciordia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastiaan M.","family":"Van Liempd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan M.","family":"Falc\u00f3n-P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesus","family":"Urman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Sangro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silve","family":"Vicent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria J.","family":"Iraburu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felipe","family":"Prosper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonard J.","family":"Nelson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesus M.","family":"Banales","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Luz","family":"Martinez-Chantar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose J. G.","family":"Marin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Braconi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Trautwein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando J.","family":"Corrales","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F. Javier","family":"Cubero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Berasain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maite G.","family":"Fernandez-Barrena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6570-3557","authenticated-orcid":false,"given":"Matias A.","family":"Avila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,5,26]]},"reference":[{"key":"2386_CR1","doi-asserted-by":"crossref","unstructured":"Brindley PJ, Bachini M, Ilyas SI, Khan SA, Loukas A, Sirica AE, et al. Cholangiocarcinoma. Nat Rev Dis Primers. 2021;7 Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/34504109\/ [cited 2 Nov 2021].","DOI":"10.1038\/s41572-021-00300-2"},{"key":"2386_CR2","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1038\/s41575-020-0310-z","volume":"17","author":"JM Banales","year":"2020","unstructured":"Banales JM, Marin JJG, Lamarca A, Rodrigues PM, Khan SA, Roberts LR, et al. Cholangiocarcinoma 2020: the next horizon in mechanisms and management. Nat Rev Gastroenterol Hepatol. 2020;17:557\u201388 Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/32606456\/ [cited 12 Dec 2020]. Nature Research.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"3","key":"2386_CR3","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1002\/hep.31803","volume":"74","author":"Y Wada","year":"2021","unstructured":"Wada Y, Shimada M, Yamamura K, Toshima T, Banwait JK, Morine Y, et al. A Transcriptomic signature for risk-stratification and recurrence prediction in intrahepatic cholangiocarcinoma. Hepatology. 2021;74(3):1371\u201383 Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/33725402\/ [cited 12 Feb 2022].","journal-title":"Hepatology"},{"issue":"1","key":"2386_CR4","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.ccell.2021.12.006","volume":"40","author":"L Dong","year":"2022","unstructured":"Dong L, Lu D, Chen R, Lin Y, Zhu H, Zhang Z, et al. Proteogenomic characterization identifies clinically relevant subgroups of intrahepatic cholangiocarcinoma. Cancer Cell. 2022;40(1):70\u201387.e15 Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/34971568\/ [cited 12 Feb 2022].","journal-title":"Cancer Cell"},{"key":"2386_CR5","doi-asserted-by":"publisher","first-page":"1662","DOI":"10.1158\/1078-0432.CCR-21-2384","volume":"28","author":"H Verdaguer","year":"2022","unstructured":"Verdaguer H, Saur\u00ed T, Acosta DA, Guardiola M, Sierra A, Hernando J, et al. ESMO scale for clinical Actionability of molecular targets driving targeted treatment in patients with cholangiocarcinoma. Clin Cancer Res. 2022;28:1662\u201371 clincanres.2384.2021. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/35042699\/ [cited 12 Feb 2022].","journal-title":"Clin Cancer Res"},{"key":"2386_CR6","doi-asserted-by":"crossref","unstructured":"Kankeu Fonkoua LA, Serrano Uson Junior PL, Mody K, Mahipal A, Borad MJ, Roberts LR. Novel and emerging targets for cholangiocarcinoma progression: therapeutic implications. Expert Opin Ther Targets. 2022:1\u201314 Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/35034558\/ [cited 12 Feb 2022].","DOI":"10.1080\/14728222.2022.2029412"},{"issue":"4","key":"2386_CR7","doi-asserted-by":"publisher","first-page":"1914","DOI":"10.1002\/hep.31862","volume":"74","author":"JG Yoon","year":"2021","unstructured":"Yoon JG, Kim MH, Jang M, Kim H, Hwang HK, Kang CM, et al. Molecular Characterization of Biliary Tract Cancer Predicts Chemotherapy and Programmed Death 1\/Programmed Death-Ligand 1 Blockade Responses. Hepatology. 2021;74(4):1914\u201331 Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/33884649\/ [cited 12 Feb 2022].","journal-title":"Hepatology"},{"issue":"1","key":"2386_CR8","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/s13046-022-02283-8","volume":"41","author":"S Mancarella","year":"2022","unstructured":"Mancarella S, Serino G, Gigante I, Cigliano A, Ribback S, Sanese P, et al. CD90 is regulated by notch1 and hallmarks a more aggressive intrahepatic cholangiocarcinoma phenotype. J Exp Clin Cancer Res. 2022;41(1):65 Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/35172861\/ [cited 21 Feb 2022].","journal-title":"J Exp Clin Cancer Res"},{"issue":"10272","key":"2386_CR9","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/S0140-6736(21)00153-7","volume":"397","author":"JW Valle","year":"2021","unstructured":"Valle JW, Kelley RK, Nervi B, Oh D-Y, Zhu AX. Biliary tract cancer. Lancet. 2021;397(10272):428\u201344 Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/33516341\/ [cited 20 Apr 2021].","journal-title":"Lancet"},{"key":"2386_CR10","doi-asserted-by":"crossref","unstructured":"Dumonceau JM, Delhaye M, Charette N, Farina A. Challenging biliary strictures: pathophysiological features, differential diagnosis, diagnostic algorithms, and new clinically relevant biomarkers - part 1. Ther Adv Gastroenterol. 2020;13 Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/32595761\/ [cited 4 Apr 2021]. SAGE Publications Ltd.","DOI":"10.1177\/1756284820927292"},{"key":"2386_CR11","doi-asserted-by":"crossref","unstructured":"Ney A, Garcia-Sampedro A, Goodchild G, Acedo P, Fusai G, Pereira SP. Biliary Strictures and Cholangiocarcinoma \u2013 Untangling a Diagnostic Conundrum. Front Oncol. 2021;11 Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/34660269\/ [cited 2021 Nov 2].","DOI":"10.3389\/fonc.2021.699401"},{"issue":"5","key":"2386_CR12","doi-asserted-by":"publisher","first-page":"332","DOI":"10.4251\/wjgo.v13.i5.332","volume":"13","author":"G Rompianesi","year":"2021","unstructured":"Rompianesi G, Di MM, Gordon-Weeks A, Montalti R, Troisi R. Liquid biopsy in cholangiocarcinoma: current status and future perspectives. World J Gastrointest Oncol. 2021;13(5):332\u201350 Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/34040697\/ [cited 13 Feb 2022].","journal-title":"World J Gastrointest Oncol"},{"issue":"9","key":"2386_CR13","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.4251\/wjgo.v13.i9.1073","volume":"13","author":"R Shotton","year":"2021","unstructured":"Shotton R, Lamarca A, Valle J, Mcnamara MG. Potential utility of liquid biopsies in the management of patients with biliary tract cancers: a review. World J Gastrointest Oncol. 2021;13(9):1073\u201385 Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/34616513\/ [cited 13 Feb 2022].","journal-title":"World J Gastrointest Oncol"},{"key":"2386_CR14","doi-asserted-by":"crossref","unstructured":"Cho MT, Gholami S, Gui D, Tejaswi SL, Fananapazir G, Abi-Jaoudeh N, et al. Optimizing the diagnosis and biomarker testing for patients with intrahepatic Cholangiocarcinoma: a multidisciplinary approach. Cancers (Basel). 2022;14(2) Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/35053557\/ [cited 13 Feb 2022].","DOI":"10.3390\/cancers14020392"},{"key":"2386_CR15","doi-asserted-by":"crossref","unstructured":"Arechederra M, Rull\u00e1n M, Amat I, Oyon D, Zabalza L, Elizalde M, et al. Next-generation sequencing of bile cell-free DNA for the early detection of patients with malignant biliary strictures. Gut. 2021; Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/34285068\/ [cited 10 Oct 2021].","DOI":"10.1136\/gutjnl-2021-325178"},{"key":"2386_CR16","doi-asserted-by":"crossref","unstructured":"Loi E, Zavattari C, Tommasi A, Moi L, Canale M, Po A, et al. HOXD8 hypermethylation as a fully sensitive and specific biomarker for biliary tract cancer detectable in tissue and bile samples. Br J Cancer. 2022; Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/35177798 [cited 21 Feb 2022].","DOI":"10.1038\/s41416-022-01738-1"},{"issue":"1","key":"2386_CR17","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1002\/hep.32125","volume":"75","author":"HM Vedeld","year":"2022","unstructured":"Vedeld HM, Grimsrud MM, Andresen K, Pharo HD, von Seth E, Karlsen TH, et al. Early and accurate detection of cholangiocarcinoma in patients with primary sclerosing cholangitis by methylation markers in bile. Hepatology. 2022;75(1):59\u201373 Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/34435693\/ [cited 2 Feb 2022].","journal-title":"Hepatology"},{"issue":"14","key":"2386_CR18","doi-asserted-by":"publisher","first-page":"4073","DOI":"10.7150\/jca.40964","volume":"11","author":"KH Son","year":"2020","unstructured":"Son KH, Ahn CB, Kim HJ, Kim JS. Quantitative proteomic analysis of bile in extrahepatic cholangiocarcinoma patients. J Cancer. 2020;11(14):4073\u201380.","journal-title":"J Cancer"},{"issue":"1","key":"2386_CR19","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s12929-019-0599-5","volume":"27","author":"T Voigtl\u00e4nder","year":"2020","unstructured":"Voigtl\u00e4nder T, Metzger J, Husi H, Kirstein MM, Pejchinovski M, Latosinska A, et al. Bile and urine peptide marker profiles: access keys to molecular pathways and biological processes in cholangiocarcinoma. J Biomed Sci. 2020;27(1):13.","journal-title":"J Biomed Sci"},{"issue":"6","key":"2386_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/cancers12061644","volume":"12","author":"JM Urman","year":"2020","unstructured":"Urman JM, Herranz JM, Uriarte I, Rull\u00e1n M, Oy\u00f3n D, Gonz\u00e1lez B, et al. Pilot multi-omic analysis of human bile from benign and malignant biliary strictures: a machine-learning approach. Cancers (Basel). 2020;12(6):1\u201330 Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/32575903\/ [cited 5 Oct 2020].","journal-title":"Cancers (Basel)"},{"issue":"6","key":"2386_CR21","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/j.dld.2012.10.008","volume":"45","author":"S De Minicis","year":"2013","unstructured":"De Minicis S, Kisseleva T, Francis H, Baroni GS, Benedetti A, Brenner D, et al. Liver carcinogenesis: rodent models of hepatocarcinoma and cholangiocarcinoma. Dig Liver Dis. 2013;45(6):450\u20139 Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/23177172\/ [cited 17 Feb 2022].","journal-title":"Dig Liver Dis"},{"issue":"1","key":"2386_CR22","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.jhep.2014.09.007","volume":"62","author":"C Raggi","year":"2015","unstructured":"Raggi C, Invernizzi P, Andersen JB. Impact of microenvironment and stem-like plasticity in cholangiocarcinoma: molecular networks and biological concepts. J Hepatol. 2015;62(1):198\u2013207. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/25220250\/ [cited 13 Feb 2022].","journal-title":"J Hepatol"},{"issue":"5","key":"2386_CR23","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1111\/jgh.15307","volume":"36","author":"MLT Nguyen","year":"2021","unstructured":"Nguyen MLT, Bui KC, Scholta T, Xing J, Bhuria V, Sipos B, et al. Targeting interleukin 6 signaling by monoclonal antibody siltuximab on cholangiocarcinoma. J Gastroenterol Hepatol. 2021;36(5):1334\u201345 Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/33091158\/ [cited 13 Feb 2022].","journal-title":"J Gastroenterol Hepatol"},{"key":"2386_CR24","doi-asserted-by":"crossref","unstructured":"Reina-Campos M, Diaz-Meco MT, Moscat J. The complexity of the serine glycine one-carbon pathway in cancer. J Cell Biol. 2019;jcb.201907022. Available from: http:\/\/www.jcb.org\/lookup\/doi\/10.1083\/jcb.201907022 [cited 11 Dec 2019].","DOI":"10.1083\/jcb.201907022"},{"key":"2386_CR25","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1111\/liv.14102","volume":"39","author":"L Fouassier","year":"2019","unstructured":"Fouassier L, Marzioni M, Afonso MB, Dooley S, Gaston K, Giannelli G, et al. Signalling networks in cholangiocarcinoma: molecular pathogenesis, targeted therapies and drug resistance. Liver Int. 2019;39:43\u201362 Blackwell Publishing Ltd.","journal-title":"Liver Int"},{"key":"2386_CR26","doi-asserted-by":"crossref","unstructured":"Chen C, Nelson LJ, \u00c1vila MA, Cubero FJ. Mitogen-activated protein kinases (MAPKs) and Cholangiocarcinoma: the missing link. Cells. 2019;8(10) Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/31569444\/ [cited 13 Feb 2022].","DOI":"10.3390\/cells8101172"},{"issue":"2","key":"2386_CR27","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1002\/hep.23709","volume":"52","author":"CM Rodr\u00edguez-Ortigosa","year":"2010","unstructured":"Rodr\u00edguez-Ortigosa CM, Banales JM, Olivas I, Uriarte I, Mar\u00edn JJG, Corrales FJ, et al. Biliary secretion of S-nitrosoglutathione is involved in the hypercholeresis induced by ursodeoxycholic acid in the normal rat. Hepatology. 2010;52(2):667\u201377 Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/20683964\/ [cited 16 Feb 2022].","journal-title":"Hepatology"},{"issue":"6","key":"2386_CR28","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1002\/hep4.1495","volume":"4","author":"FJ Cubero","year":"2020","unstructured":"Cubero FJ, Mohamed MR, Woitok MM, Zhao G, Hatting M, Nevzorova YA, et al. Loss of c-Jun N-terminal Kinase 1 and 2 Function in Liver Epithelial Cells Triggers Biliary Hyperproliferation Resembling Cholangiocarcinoma. Hepatol Commun. 2020;4(6):834\u201351 Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/32490320\/ [cited 16 Jul 2020].","journal-title":"Hepatol Commun"},{"key":"2386_CR29","doi-asserted-by":"crossref","unstructured":"Manieri E, Folgueira C, Rodr\u00edguez ME, Leiva-Vega L, Esteban-Lafuente L, Chen C, et al. JNK-mediated disruption of bile acid homeostasis promotes intrahepatic cholangiocarcinoma. Proc Natl Acad Sci. 2020:202002672 Available from: http:\/\/www.pnas.org\/lookup\/doi\/10.1073\/pnas.2002672117 [cited 13 Jul 2020].","DOI":"10.1073\/pnas.2002672117"},{"issue":"6","key":"2386_CR30","doi-asserted-by":"publisher","first-page":"2380","DOI":"10.1002\/hep.31642","volume":"73","author":"L Colyn","year":"2021","unstructured":"Colyn L, B\u00e1rcena-Varela M, \u00c1lvarez-Sola G, Latasa MU, Uriarte I, Santamar\u00eda E, et al. Dual Targeting of G9a and DNA Methyltransferase-1 for the Treatment of Experimental Cholangiocarcinoma. Hepatology. 2021;73(6):2380\u201396 Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/33222246\/ [cited 7 Dec 2021].","journal-title":"Hepatology"},{"issue":"2","key":"2386_CR31","first-page":"388","volume":"70","author":"M Barcena-Varela","year":"2021","unstructured":"Barcena-Varela M, Paish H, Alvarez L, Uriarte I, Latasa MU, Santamaria E, et al. Epigenetic mechanisms and metabolic reprogramming in fibrogenesis: dual targeting of G9a and DNMT1 for the inhibition of liver fibrosis. Gut. 2021;70(2):388\u2013400 Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/32327527\/ [cited 27 Jun 2020].","journal-title":"Gut"},{"key":"2386_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-1-0716-1936-0_1","volume":"2420","author":"S Ciordia","year":"2022","unstructured":"Ciordia S, Alvarez-Sola G, Rull\u00e1n M, Urman JM, \u00c1vila MA, Corrales FJ. Bile processing protocol for improved proteomic analysis. Methods Mol Biol. 2022;2420:1\u201310 Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/34905161\/ [cited 16 Feb 2022].","journal-title":"Methods Mol Biol"},{"key":"2386_CR33","doi-asserted-by":"crossref","unstructured":"Ciordia S, Alvarez-Sola G, Rull\u00e1n M, Urman JM, \u00c1vila MA, Corrales FJ. Digging deeper into bile proteome. J Proteome. 2021;230 Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/32932008\/ [cited 25 Oct 2020].","DOI":"10.1016\/j.jprot.2020.103984"},{"issue":"1","key":"2386_CR34","first-page":"1013","volume":"2","author":"S Zach","year":"2015","unstructured":"Zach S, Birgin E, R\u00fcckert F. Primary cholangiocellular carcinoma cell lines. J Stem Cell Res Transplant. 2015;2(1):1013.","journal-title":"J Stem Cell Res Transplant"},{"issue":"23","key":"2386_CR35","doi-asserted-by":"publisher","first-page":"4033","DOI":"10.1038\/s41388-021-01824-3","volume":"40","author":"S Carotti","year":"2021","unstructured":"Carotti S, Zingariello M, Francesconi M, D\u2019Andrea L, Latasa MU, Colyn L, et al. Fragile X mental retardation protein in intrahepatic cholangiocarcinoma: regulating the cancer cell behavior plasticity at the leading edge. Oncogene. 2021;40(23):4033\u201349 Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/34017076\/ [cited 16 Jan 2022].","journal-title":"Oncogene"},{"issue":"6","key":"2386_CR36","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1016\/j.cmet.2013.11.004","volume":"18","author":"J Ding","year":"2013","unstructured":"Ding J, Li T, Wang X, Zhao E, Choi J-H, Yang L, et al. The histone H3 methyltransferase G9A epigenetically activates the serine-glycine synthesis pathway to sustain cancer cell survival and proliferation. Cell Metab. 2013;18(6):896\u2013907 Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24315373 [cited 21 Oct 2019].","journal-title":"Cell Metab"},{"issue":"4","key":"2386_CR37","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1053\/j.gastro.2017.10.043","volume":"154","author":"A Lampis","year":"2018","unstructured":"Lampis A, Carotenuto P, Vlachogiannis G, Cascione L, Hedayat S, Burke R, et al. MIR21 Drives Resistance to Heat Shock Protein 90 Inhibition in Cholangiocarcinoma. Gastroenterology. 2018;154(4):1066\u20131079.e5 Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/29113809\/ [cited 16 Feb 2022.","journal-title":"Gastroenterology"},{"key":"2386_CR38","unstructured":"Loeuillard E, Fischbach SR, Gores GJ, Rizvi S. Animal models of cholangiocarcinoma. Biochim Biophys Acta Mol basis Dis. 2018; Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0925443918301248 [cited 16 Apr 2019]."},{"issue":"3","key":"2386_CR39","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.clnu.2012.10.008","volume":"32","author":"SAWG Dello","year":"2013","unstructured":"Dello SAWG, Neis EPJG, de Jong MC, van Eijk HMH, Kicken CH, Olde Damink SWM, et al. Systematic review of ophthalmate as a novel biomarker of hepatic glutathione depletion. Clin Nutr. 2013;32(3):325\u201330 Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/23182341\/ [cited 20 Feb 2022].","journal-title":"Clin Nutr"},{"issue":"5","key":"2386_CR40","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1158\/2159-8290.CD-20-0304","volume":"11","author":"Q Zhang","year":"2021","unstructured":"Zhang Q, Ma C, Duan Y, Heinrich B, Rosato U, Diggs LP, et al. Gut Microbiome Directs Hepatocytes to Recruit MDSCs and Promote Cholangiocarcinoma. Cancer Discov. 2021;11(5):1248\u201367 Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/33323397\/ [cited 20 Feb 2022].","journal-title":"Cancer Discov"},{"issue":"Suppl 1","key":"2386_CR41","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1002\/hep.31410","volume":"73","author":"L Fabris","year":"2021","unstructured":"Fabris L, Sato K, Alpini G, Strazzabosco M. The tumor microenvironment in cholangiocarcinoma progression. Hepatology. 2021;73(Suppl 1):75\u201385 Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/32500550\/ [cited 20 Feb 2022].","journal-title":"Hepatology"},{"issue":"4","key":"2386_CR42","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/j.ccr.2011.03.002","volume":"19","author":"A Fukuda","year":"2011","unstructured":"Fukuda A, Wang SC, Morris JP, Folias AE, Liou A, Kim GE, et al. Stat3 and MMP7 contribute to pancreatic ductal adenocarcinoma initiation and progression. Cancer Cell. 2011;19(4):441\u201355 Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/21481787\/ [cited 20 Feb 2022].","journal-title":"Cancer Cell"},{"issue":"4","key":"2386_CR43","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1158\/2159-8290.CD-13-0646","volume":"4","author":"Z Zhu","year":"2014","unstructured":"Zhu Z, Aref AR, Cohoon TJ, Barbie TU, Imamura Y, Yang S, et al. Inhibition of KRAS-driven tumorigenicity by interruption of an autocrine cytokine circuit. Cancer Discov. 2014;4(4):453\u201365 Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/24444711\/ [cited 20 Feb 2022].","journal-title":"Cancer Discov"},{"key":"2386_CR44","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1016\/j.isci.2019.10.044","volume":"21","author":"DK Lau","year":"2019","unstructured":"Lau DK, Mouradov D, Wasenang W, Luk IY, Scott CM, Williams DS, et al. Genomic Profiling of Biliary Tract Cancer Cell Lines Reveals Molecular Subtypes and Actionable Drug Targets. iScience. 2019;21:624\u201337 Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/31731200\/ [cited 29 Mar 2021].","journal-title":"iScience"},{"key":"2386_CR45","doi-asserted-by":"crossref","unstructured":"Pant K, Richard S, Peixoto E, Gradilone SA. Role of glucose metabolism reprogramming in the pathogenesis of cholangiocarcinoma. Front Med. 2020;7 Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/32318579\/ [cited 10 Sep 2020]. Frontiers Media S.A.","DOI":"10.3389\/fmed.2020.00113"},{"key":"2386_CR46","doi-asserted-by":"crossref","unstructured":"Pupo E, Avanzato D, Middonti E, Bussolino F, Lanzetti L. KRAS-driven metabolic rewiring reveals novel actionable targets in Cancer. Front Oncol. 2019;9 Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/31544066\/ [cited 24 Feb 2022].","DOI":"10.3389\/fonc.2019.00848"},{"issue":"18","key":"2386_CR47","doi-asserted-by":"publisher","first-page":"6904","DOI":"10.1073\/pnas.1204176109","volume":"109","author":"J Ye","year":"2012","unstructured":"Ye J, Mancuso A, Tong X, Ward PS, Fan J, Rabinowitz JD, et al. Pyruvate kinase M2 promotes de novo serine synthesis to sustain mTORC1 activity and cell proliferation. Proc Natl Acad Sci U S A. 2012;109(18):6904\u20139 Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22509023 [cited 21 Oct 2019].","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"2386_CR48","doi-asserted-by":"publisher","first-page":"78","DOI":"10.3390\/cancers14010078","volume":"14","author":"C Chen","year":"2021","unstructured":"Chen C, Wu H, Ye H, Tortajada A, Rodr\u00edguez-Perales S, Torres-Ruiz R, et al. Activation of the unfolded protein response (UPR) is associated with Cholangiocellular injury, fibrosis and carcinogenesis in an experimental model of Fibropolycystic liver disease. Cancers (Basel). 2021;14(1):78 Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/35008241\/ [cited 12 Jan 2022].","journal-title":"Cancers (Basel)"},{"issue":"6","key":"2386_CR49","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1038\/nchembio.2070","volume":"12","author":"ME Pacold","year":"2016","unstructured":"Pacold ME, Brimacombe KR, Chan SH, Rohde JM, Lewis CA, Swier LJYM, et al. A PHGDH inhibitor reveals coordination of serine synthesis and one-carbon unit fate. Nat Chem Biol. 2016;12(6):452\u20138 Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27110680 [cited 21 Oct 2019].","journal-title":"Nat Chem Biol"},{"issue":"10","key":"2386_CR50","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.3390\/life11101082","volume":"11","author":"C Poulard","year":"2021","unstructured":"Poulard C, Noureddine LM, Pruvost L, Le Romancer M. Structure, Activity, and Function of the Protein Lysine Methyltransferase G9a. Life. 2021;11(10):1082 Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/34685453\/ [cited 4 Nov 2021].","journal-title":"Life"},{"issue":"5","key":"2386_CR51","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1016\/j.jhep.2020.05.039","volume":"73","author":"M Zhang","year":"2020","unstructured":"Zhang M, Yang H, Wan L, Wang Z, Wang H, Ge C, et al. Single-cell transcriptomic architecture and intercellular crosstalk of human intrahepatic cholangiocarcinoma. J Hepatol. 2020;73(5):1118\u201330 Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/32505533\/ [cited 20 Feb 2022].","journal-title":"J Hepatol"},{"issue":"1","key":"2386_CR52","first-page":"58","volume":"1","author":"C Johnson","year":"2012","unstructured":"Johnson C, Han Y, Hughart N, McCarra J, Alpini G, Meng F. Interleukin-6 and its receptor, key players in hepatobiliary inflammation and cancer. Transl Gastrointest Cancer. 2012;1(1):58\u201370 Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/22724089\/ [cited 6 Mar 2022].","journal-title":"Transl Gastrointest Cancer"},{"issue":"10","key":"2386_CR53","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.15252\/emmm.201606798","volume":"8","author":"J Goveia","year":"2016","unstructured":"Goveia J, Pircher A, Conradi L, Kalucka J, Lagani V, Dewerchin M, et al. Meta-analysis of clinical metabolic profiling studies in cancer: challenges and opportunities. EMBO Mol Med. 2016;8(10):1134\u201342 Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/27601137\/ [cited 20 Feb 2022].","journal-title":"EMBO Mol Med"},{"issue":"2","key":"2386_CR54","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1038\/s42255-020-00329-9","volume":"3","author":"SL Geeraerts","year":"2021","unstructured":"Geeraerts SL, Heylen E, De Keersmaecker K, Kampen KR. The ins and outs of serine and glycine metabolism in cancer. Nat Metab. 2021;3(2):131\u201341 Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/33510397\/ [cited 23 Feb 2022].","journal-title":"Nat Metab"},{"issue":"2","key":"2386_CR55","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1111\/j.1872-034X.2007.00016.x","volume":"37","author":"P Laverman","year":"2007","unstructured":"Laverman P, Blokx WAM, te Morsche RHM, Frielink C, Boerman OC, Oyen WJG, et al. [(18)F]FDG accumulation in an experimental model of multistage progression of cholangiocarcinoma. Hepatol Res. 2007;37(2):127\u201332 Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/17300708\/ [cited 10 Mar 2022].","journal-title":"Hepatol Res"},{"key":"2386_CR56","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.lfs.2018.09.009","volume":"210","author":"W Zhao","year":"2018","unstructured":"Zhao W, Yang S, Chen J, Zhao J, Dong J. Forced overexpression of FBP1 inhibits proliferation and metastasis in cholangiocarcinoma cells via Wnt\/\u03b2-catenin pathway. Life Sci. 2018;210:224\u201334.","journal-title":"Life Sci"},{"key":"2386_CR57","doi-asserted-by":"crossref","unstructured":"Ning S, Ma S, Saleh AQ, Guo L, Zhao Z, Chen Y. SHMT2 overexpression predicts poor prognosis in intrahepatic Cholangiocarcinoma. Gastroenterol Res Pract. 2018;2018 Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/30228815\/ [cited 10 Mar 2022].","DOI":"10.1155\/2018\/4369253"},{"issue":"6","key":"2386_CR58","doi-asserted-by":"publisher","first-page":"695","DOI":"10.21873\/cgp.20224","volume":"17","author":"H Kato","year":"2020","unstructured":"Kato H, Tateishi K, Fujiwara H, Ijichi H, Yamamoto K, Nakatsuka T, et al. Deletion of Histone Methyltransferase G9a Suppresses Mutant Kras-driven Pancreatic Carcinogenesis. Cancer Genomics Proteomics. 2020;17(6):695\u2013705 Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/33099471\/ [cited 11 Nov 2020].","journal-title":"Cancer Genomics Proteomics"},{"key":"2386_CR59","doi-asserted-by":"crossref","unstructured":"Urrutia G, de Assuncao TM, Mathison AJ, Salmonson A, Kerketta R, Zeighami A, et al. Inactivation of the Euchromatic histone-lysine N-methyltransferase 2 pathway in pancreatic epithelial cells antagonizes Cancer initiation and pancreatitis-associated promotion by altering growth and immune gene expression networks. Front Cell Dev Biol. 2021;9 Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/34249932\/ [cited 20 Mar 2022].","DOI":"10.3389\/fcell.2021.681153"},{"issue":"8","key":"2386_CR60","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.15252\/embr.201744060","volume":"18","author":"C Poulard","year":"2017","unstructured":"Poulard C, Bittencourt D, Wu D, Hu Y, Gerke DS, Stallcup MR. A post-translational modification switch controls coactivator function of histone methyltransferases G9a and GLP. EMBO Rep. 2017;18(8):1442\u201359 Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/28615290\/ [cited 26 Feb 2022].","journal-title":"EMBO Rep"},{"key":"2386_CR61","doi-asserted-by":"crossref","unstructured":"Maeda R, Tachibana M. HP1 maintains protein stability of H3K9 methyltransferases and demethylases. EMBO Rep. 2022; Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/35166421\/ [cited 22 Feb 2022].","DOI":"10.15252\/embr.202153581"},{"issue":"3","key":"2386_CR62","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1016\/j.bbrc.2018.04.137","volume":"500","author":"LY Chen","year":"2018","unstructured":"Chen LY, Cheng CS, Qu C, Wang P, Chen H, Meng ZQ, et al. CBX3 promotes proliferation and regulates glycolysis via suppressing FBP1 in pancreatic cancer. Biochem Biophys Res Commun. 2018;500(3):691\u20137 Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/29678579\/ [cited 20 Mar 2022].","journal-title":"Biochem Biophys Res Commun"},{"key":"2386_CR63","doi-asserted-by":"crossref","unstructured":"Lin H, Zhao X, Xia L, Lian J, You J. Clinicopathological and prognostic significance of CBX3 expression in human Cancer: a systematic review and Meta-analysis. Dis Markers. 2020;2020 Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/33273987\/ [cited 21 Mar 2022].","DOI":"10.1155\/2020\/2412741"},{"issue":"14","key":"2386_CR64","doi-asserted-by":"publisher","first-page":"3834","DOI":"10.1158\/0008-5472.CAN-17-3571","volume":"78","author":"H Alam","year":"2018","unstructured":"Alam H, Li N, Dhar SS, Wu SJ, Lv J, Chen K, et al. HP1\u03b3 Promotes Lung Adenocarcinoma by Downregulating the Transcription-Repressive Regulators NCOR2 and ZBTB7A. Cancer Res. 2018;78(14):3834\u201348 Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/29764865\/ [cited 20 Mar 2022].","journal-title":"Cancer Res"}],"container-title":["Journal of Experimental &amp; Clinical Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13046-022-02386-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13046-022-02386-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13046-022-02386-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,26]],"date-time":"2022-05-26T08:03:40Z","timestamp":1653552220000},"score":1,"resource":{"primary":{"URL":"https:\/\/jeccr.biomedcentral.com\/articles\/10.1186\/s13046-022-02386-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,26]]},"references-count":64,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["2386"],"URL":"https:\/\/doi.org\/10.1186\/s13046-022-02386-2","relation":{},"ISSN":["1756-9966"],"issn-type":[{"value":"1756-9966","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,26]]},"assertion":[{"value":"5 April 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 May 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Human iCCA samples were collected at San Raffaele Hospital, Milan, Italy. The study was approved by the local Ethical Committee (approval # 113\/INT\/2021) in compliance with the Helsinki Declaration. Informed consent was obtained from all patients.For the rat TTA model the experimental protocol was approved and performed according to the guidelines of the Animal Care Committee of the University of Navarra (approval #068\u201316). Experiments in mice were approved by the (Autonomous Region of Madrid Ethical Committee for Animal Experimentation (approval #PROEX210\/18 and 125.1\/20).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"183"}}